Mirxes Holding Company Limited (02629.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

May 6May 11May 14May 19May 22May 28Jun 2Jun 5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

HKD 3.66B

MomentumView details →

1D Return

−20.24%

YTD Return

−71.99%

RSI (14)

31.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

HKD 3.66B

RSI (14)

31.7

MomentumView details →

1D Return

−20.24%

YTD Return

−71.99%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for 02629.HK.

Similar companies

Qyuns Therapeutics Co., Ltd.02509.HK AbCellera Biologics Inc.ABCL Arcus Biosciences, Inc.RCUS Denali Therapeutics Inc.DNLI Shanghai Haohai Biological Technology Co., Ltd.06826.HK 普莱柯603566.SH Find similar companies →

Latest newsMore news →

No recent news for 02629.HK.